Related Experiment Video
Updated: Oct 22, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Factors Associated with 30-Day Mortality in Patients after Percutaneous Endoscopic Gastrostomy
Diego L Lima1, Luiz Eduardo C Miranda2, Marcel Rolland Ciro da Penha2
1Department of Surgery, Montefiore Medical Center, The Bronx, New York, USA.
Insights
Anemia and prior intensive care unit (ICU) admission are key risk factors for early mortality following percutaneous endoscopic gastrostomy (PEG) tube placement. Identifying these predictors can help clinicians optimize patient selection for long-term tube feeding.
Area of Science:
- Gastroenterology
- Critical Care Medicine
- Geriatrics
Background:
- Percutaneous endoscopic gastrostomy (PEG) is a standard procedure for long-term enteral nutrition.
- Early mortality after PEG placement is a significant concern in vulnerable patient populations.
Purpose of the Study:
- To identify risk factors associated with early mortality within 30 days of PEG insertion.
- To evaluate the impact of preoperative conditions on post-PEG outcomes.
Main Methods:
- Retrospective survival analysis of 277 patients undergoing PEG placement.
- Kaplan-Meier survival analysis and multivariable Cox proportional regression models were employed.
- Medical records were reviewed to extract relevant patient data and outcomes.
Main Results:
- The 30-day mortality rate following PEG was 13%.
- Preoperative intensive care unit (ICU) hospitalization was a significant predictor of early mortality (HR 1.79).
- Lower hemoglobin levels (anemia) were also associated with increased early mortality risk (HR 0.91).
Conclusions:
- Anemia and previous ICU admission are significant predictors of mortality within four weeks of PEG tube insertion.
- These findings suggest that physicians should carefully consider these risk factors when deciding on PEG indications.
- Optimizing preoperative hemoglobin levels and reassessing the need for PEG in patients with prior ICU stays may improve outcomes.
Introduction:
Percutaneous endoscopic gastrostomy (PEG) is the main accepted method for long-term tube feeding. The aim of this study is to investigate the risk factors associated with early mortality after PEG.
Methods:
It is a retrospective survival analysis in a tertiary-level hospital. We reviewed the medical records of 277 patients with PEG placement. The data were analyzed by the Kaplan-Meier method. Multivariable Cox proportional regression models were also built to test the effects of PEG on mortality.
Results:
A total of 277 patients who submitted to PEG were studied. One-hundred and sixty (58%) were female, mean age of 73.3 ± 15.7 years. Ninety-three patients (33.6%) had diabetes mellitus and 165 (59.6%) had blood hypertension. The indications for PEG placement were chronic neurologic dysphagia in 247 (89.5%) patients and tumors and other diseases in 29 (10.5%). The 30 days proportional mortality probability rate was 13%. In a multivariate Cox proportional regression model, preoperative ICU hospitalization (HR 1.79, 95% CI 1.36-2.36, P = 0.000) and hemoglobin (HR 0.91, 95% CI 0.85-0.98, P = 0.015) were predictors of early mortality.
Conclusion:
In patients who had underwent PEG tube insertion for long-term nutrition, anemia and previous ICU admission were predictors of mortality at four weeks. These factors may guide physicians to discourage the indication for PEG.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

